Bioequivalence Study of Amoxicillin Dispersible 600 mg Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
This study compared the relative bioavailability (rate and extent of absorption) of
amoxicillin tablets for oral suspension 600 mg by Ranbaxy Laboratories Limited with that of
Amoxil ® for oral suspension 400 mg/ 5 mL by SmithKline Beecham Pharmaceuticals following
single oral dose (600 mg) in healthy, adult, subjects under fasting conditions using a
randomized two-way crossover design.